Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment can safely improve short-term vision in acute NAION patients.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

A young man had vision loss, hair loss, and other symptoms, but tests showed mostly normal results except for slightly high protein in spinal fluid.

The woman's facial symptoms are best explained by primary Sjögren’s Syndrome.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Surgical treatment for cubital tunnel syndrome can be effective using clinical tests without electrodiagnostics.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Oral zinc sulphate is an effective and safe treatment for thallium poisoning.

Thallium exposure can cause serious health issues, including nerve damage and hair loss.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Taking alfuzosin and finasteride together caused temporary vision loss in a glaucoma patient, but switching to tamsulosin helped.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

Hair loss and polyneuropathy improved, but severe vision impairment persisted.

A woman poisoned with thallium was successfully treated with activated charcoal and Prussian blue.

A patient with steroid sulfatase deficiency had a unique hair pattern and a brain malformation not previously linked to the condition.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Several doctors received research grants, new workshops and conferences were announced, and new officers were elected.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

Thallium poisoning causes pain, hair loss, and nerve issues, treatable with hemoperfusion and hemodialysis.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Finasteride, often used for hair loss, can potentially cause cataracts.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.